Abbott laboratories
ABT AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock excels in value rating and ranks among the top in dividend scores. It's a prime choice for long-term accumulation. For optimal entry, check our trend and swing trading ratings.
ABT Current Performance
0.57%
Abbott laboratories
1.69%
Avg of Sector
-0.39%
S&P500
Top 10 High Relevance to ABT
| Symbol | Value | Trend | Swing Trading | Whale Interest | Dividend | Market Cap | Add to Watchlist |
|---|---|---|---|---|---|---|---|
TMO Thermo fisher scientific inc. | 3 | 4 | 5 | 2 | 3 | 190.9B | |
DHR Danaher corporation | 5 | 4 | 5 | 3 | 3 | 161.8B | |
A Agilent technologies, inc. | 5 | 4 | 5 | 2 | 3 | 37.6B | |
IDXX Idexx laboratories incorporated | 2 | 4 | 5 | 3 | 1 | 43.4B | |
LH Laboratory corporation of america holdings | 3 | 4 | 5 | 3 | 1 | 18.5B |
- TMO Thermo fisher scientific inc.Value 3Trend 4Swing Trading 5Whale Interest 2Dividend 3Market Cap 190.9BSee more
ABT Profile
Abbott Laboratories is a global healthcare company. The Company's portfolio of technologies spans the spectrum of healthcare, with businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.